Insulin-like growth factors: the unrecognised oncogenes.
作者信息
Westley B R, May F E
出版信息
Br J Cancer. 1995 Nov;72(5):1065-6. doi: 10.1038/bjc.1995.465.
Abstract
摘要
相似文献
1
Insulin-like growth factors: the unrecognised oncogenes.胰岛素样生长因子：未被识别的癌基因。
Br J Cancer. 1995 Nov;72(5):1065-6. doi: 10.1038/bjc.1995.465.
2
The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?胰岛素样生长因子与胰岛素信号系统：乳腺癌治疗的一个有吸引力的靶点？
Horm Metab Res. 2003 Nov-Dec;35(11-12):857-71. doi: 10.1055/s-2004-814142.
3
Oncogenes reach a milestone.
Science. 1994 Dec 23;266(5193):1942-4. doi: 10.1126/science.7801118.
4
Oncogenes in solid human tumours.人类实体瘤中的癌基因。
Nature. 1982 Dec 9;300(5892):539-42. doi: 10.1038/300539a0.
5
Insulin-like growth factors and neoplasia.胰岛素样生长因子与肿瘤形成
Nat Rev Cancer. 2004 Jul;4(7):505-18. doi: 10.1038/nrc1387.
6
Tissue markers of colon cancer risk.结肠癌风险的组织标志物。
Gastrointest Endosc. 1999 Mar;49(3 Pt 2):S50-9. doi: 10.1016/s0016-5107(99)70526-2.
7
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.胰岛素样生长因子II在癌基因诱导的肿瘤发生中提供的第二种信号。
Nature. 1994 Jun 2;369(6479):414-8. doi: 10.1038/369414a0.
8
Oncogene-mediated transformation of fetal rat colon in vitro.癌基因介导的体外胎鼠结肠转化
Oncogene. 1992 May;7(5):885-93.
9
Growth factors in breast cancer: mitogenesis to transformation.乳腺癌中的生长因子：从有丝分裂到细胞转化
J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):69-78. doi: 10.1016/0960-0760(92)90189-p.
10
Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.胰岛素样生长因子1受体激活c-SRC并在体外改变结肠癌的转化和运动能力。
Anticancer Res. 2003 Mar-Apr;23(2B):1517-24.
引用本文的文献
1
Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation.I型胰岛素样生长因子受体在伴有和不伴有Ras途径激活的HER2、FGFR2和MET未扩增胃癌中的重要性。
Oncotarget. 2016 Aug 23;7(34):54445-54462. doi: 10.18632/oncotarget.10642.
2
Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.胰岛素样生长因子对于防止雌激素反应性乳腺癌细胞的失巢凋亡至关重要：I型胰岛素样生长因子受体及PI3激酶/蛋白激酶B信号通路的重要性。
Mol Cancer. 2016 Jan 22;15:8. doi: 10.1186/s12943-015-0482-2.
3
A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors.肥胖引发的 21 世纪癌症流行：胰岛素、糖尿病和胰岛素样生长因子的参与。
Int J Endocrinol. 2013;2013:632461. doi: 10.1155/2013/632461. Epub 2013 Jul 31.
4
The coexistence of an intrasellar adenoma, lymphocytic hypophysitis, and primary pituitary lymphoma in a patient with acromegaly.一名肢端肥大症患者存在鞍内腺瘤、淋巴细胞性垂体炎和原发性垂体淋巴瘤共存的情况。
Case Rep Endocrinol. 2011;2011:941738. doi: 10.1155/2011/941738. Epub 2011 Oct 26.
5
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.生长激素释放激素拮抗剂通过使 ERK 和 Akt 激酶失活来抑制雄激素非依赖性前列腺癌的生长。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1655-60. doi: 10.1073/pnas.1120588109. Epub 2012 Jan 18.
6
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.生长激素释放激素（GHRH）拮抗剂可减少实验性良性前列腺增生中的前列腺体积。
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3755-60. doi: 10.1073/pnas.1018086108. Epub 2011 Feb 14.
7
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.肿瘤相关抗原自身抗体作为肝癌和其他实体瘤的诊断生物标志物。
Expert Rev Mol Diagn. 2010 Apr;10(3):321-8. doi: 10.1586/erm.10.12.
8
Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines.敲低生长激素释放激素的基因表达可抑制人癌细胞系的增殖。
Br J Cancer. 2008 Jun 3;98(11):1790-6. doi: 10.1038/sj.bjc.6604386. Epub 2008 May 27.
9
Autoantibodies to tumor-associated antigens: reporters from the immune system.肿瘤相关抗原自身抗体：来自免疫系统的报告分子
Immunol Rev. 2008 Apr;222:328-40. doi: 10.1111/j.1600-065X.2008.00611.x.
10
Energy balance, insulin resistance biomarkers, and breast cancer risk.能量平衡、胰岛素抵抗生物标志物与乳腺癌风险。
Cancer Detect Prev. 2007;31(3):214-9. doi: 10.1016/j.cdp.2007.04.003. Epub 2007 Jul 23.
本文引用的文献
1
Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer.人乳腺癌中的血浆胰岛素样生长因子-1（IGF-1）浓度
Eur J Cancer. 1993;29A(4):492-7. doi: 10.1016/s0959-8049(05)80137-6.
2
Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.人胰岛素样生长因子I受体突变体在体内对肿瘤发生的显性负抑制作用。
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2181-5. doi: 10.1073/pnas.91.6.2181.
3
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
EMBO J. 1994 Jul 15;13(14):3286-95. doi: 10.1002/j.1460-2075.1994.tb06630.x.
4
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.胰岛素样生长因子II在癌基因诱导的肿瘤发生中提供的第二种信号。
Nature. 1994 Jun 2;369(6479):414-8. doi: 10.1038/369414a0.
5
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II).表达胰岛素样生长因子II（IGF-II）的转基因小鼠中的乳腺癌。
Br J Cancer. 1995 Nov;72(5):1189-93. doi: 10.1038/bjc.1995.484.
6
c phosphorylation and activation of the IGF-I receptor in src-transformed cells.
J Biol Chem. 1994 Nov 4;269(44):27315-21.
7
Disproportionate growth in mice with Igf-2 transgenes.携带Igf-2转基因的小鼠生长比例失调。
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10365-9. doi: 10.1073/pnas.91.22.10365.
8
Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice.胰岛素样生长因子-II转基因小鼠的身体成分改变及多种恶性肿瘤发生频率增加。
J Biol Chem. 1994 May 13;269(19):13779-84.
9
Colonic polyps in patients with acromegaly.肢端肥大症患者的结肠息肉
Ann Intern Med. 1982 Jul;97(1):27-30. doi: 10.7326/0003-4819-97-1-27.
10
Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin.卵泡发育过程中人类颗粒细胞中的芳香化酶活性以及促卵泡激素和胰岛素的调节作用。
Am J Obstet Gynecol. 1984 Mar 1;148(5):657-62. doi: 10.1016/0002-9378(84)90769-5.
Zotero 插件